SCHEMBL4387213

SCHEMBL4387213

COc1cc(COCCC(C)C)ccc1OP(=O)(O)O

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 2/20 0.42
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
INPPL1 O15357 2/20 0.40
LDHA P00338 1/20 0.40
MRGPRX1 Q96LB2 1/20 0.39
STAT3 P40763 1/20 0.39
INPP5A Q14642 1/20 0.38
FDPS P14324 1/20 0.38
ALOX15 P16050 1/20 0.37
ALOX12 P18054 1/20 0.37
CA2 P00918 1/20 0.37
HTT P42858 2/20 0.37
TSHR P16473 1/20 0.37
GAA P10253 1/20 0.36
PKM P14618 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4396133 0.83 S1PR2 (0.46) SMN1; SMN2KDM4EHDAC1HDAC2INPPL1
SCHEMBL4383898 0.81 S1PR2 (0.52)
SCHEMBL25657154 0.81 LDHA (0.53) ALDH1A1INPPL1LDHASTAT3INPP5A
SCHEMBL4387210 0.80 HDAC1 (0.53) ALDH1A1SMN1; SMN2KDM4EHDAC1HDAC2
SCHEMBL15259646 0.79 CALM1 (0.50) ALDH1A1SMN1; SMN2KDM4EHDAC1HDAC2
SCHEMBL21402273 0.78 ALOX15 (0.58) ALOX15ALOX12TSHRGAAKMT2A
SCHEMBL31512861 0.78 FOS (0.58) ALDH1A1ALOX15ALOX12TSHRGAA
SCHEMBL580129 0.78 FOS (0.58) ALDH1A1ALOX15ALOX12TSHRGAA
SCHEMBL14830222 0.76 STAT3 (0.53) ALDH1A1KDM4ELDHASTAT3ALOX15
SCHEMBL25019645 0.76 INPPL1 (0.47) ALDH1A1SMN1; SMN2KDM4EINPPL1LDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11160734-B2 Personal care compositions comprising shaped abrasive particles THE PROCTER & GAMBLE COMPANY (US) 2021-11-02 US disclosed
EP-2720666-B1 PERSONAL CARE COMPOSITIONS COMPRISING SHAPED ABRASIVE PARTICLES PROCTER & GAMBLE (US) 2019-03-20 EP disclosed
US-20170312190-A1 PERSONAL CARE COMPOSITIONS COMPRISING SHAPED ABRASIVE PARTICLES PROCTER & GAMBLE (US) 2017-11-02 US disclosed
US-9675531-B2 Personal care compositions comprising shaped abrasive particles THE PROCTER & GAMBLE COMPANY (US) 2017-06-13 US disclosed
US-20160367091-A9 Personal Care Compositions Comprising a Di-Amido Gellant and Methods of Using THE PROCTER & GAMBLE COMPANY 2016-12-22 US disclosed
US-9271912-B2 Personal care compositions comprising a pH tuneable gellant and methods of using THE PROCTER & GAMBLE COMPANY (US) 2016-03-01 US disclosed
EP-2720666-A2 PERSONAL CARE COMPOSITIONS COMPRISING SHAPED ABRASIVE PARTICLES The Procter and Gamble Company (US) 2014-04-23 EP disclosed
EP-2717966-A2 PERSONAL CARE COMPOSITIONS COMPRISING A DI-AMIDO GELLANT AND METHODS OF USING The Procter and Gamble Company (US) 2014-04-16 EP disclosed
EP-2717967-A2 PERSONAL CARE COMPOSITIONS COMPRISING A pH TUNEABLE GELLANT AND METHODS OF USING The Procter & Gamble Company (US) 2014-04-16 EP disclosed
US-20130336902-A1 Personal Care Compositions Comprising a Di-Amido Gellant and Methods of Using FERNANDEZ PRIETO SUSANA (ES) 2013-12-19 US disclosed
US-20130336903-A1 Personal Care Compositions Comprising a pH Tuneable Gellant and Methods of Using THE PROCTER & GAMBLE COMPANY 2013-12-19 US disclosed
US-20130039961-A1 Personal Care Compositions Comprising Shaped Abrasive Particles THE PROCTER & GAMBLE COMPANY 2013-02-14 US disclosed
WO-2012177757-A2 PERSONAL CARE COMPOSITIONS COMPRISING SHAPED ABRASIVE PARTICLES THE PROCTER & GAMBLE COMPANY (US) 2012-12-27 WO disclosed
WO-2012174091-A2 PERSONAL CARE COMPOSITIONS COMPRISING A pH TUNEABLE GELLANT AND METHODS OF USING THE PROCTER & GAMBLE COMPANY (US) 2012-12-20 WO disclosed
WO-2012174096-A2 PERSONAL CARE COMPOSITIONS COMPRISING A DI-AMIDO GELLANT AND METHODS OF USING THE PROCTER & GAMBLE COMPANY (US) 2012-12-20 WO disclosed
EP-2120843-A1 PERSONAL CARE KIT HAVING SKIN CARE COMPOSITIONS WITH A READILY PERCEPTIBLE DIFFERENCE The Procter and Gamble Company (US) 2009-11-25 EP disclosed
US-20090017080-A1 PERSONAL CARE KIT HAVING SKIN CARE COMPOSITIONS WITH A READILY PERCEPTIBLE DIFFERENCE THE PROCTER & GAMBLE COMPANY 2009-01-15 US disclosed
WO-2008112964-A1 PERSONAL CARE KIT HAVING SKIN CARE COMPOSITIONS WITH A READILY PERCEPTIBLE DIFFERENCE THE PROCTER & GAMBLE COMPANY (US) 2008-09-18 WO disclosed
EP-0837862-A1 WARMING COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 1998-04-29 EP disclosed
WO-1997002273-A1 WARMING COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 1997-01-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170312190-A1 PERSONAL CARE COMPOSITIONS COMPRISING SHAPED ABRASIVE PARTICLES POLR1C, PLOD3, C9 ALDH1A1 2882/4885SMN1; SMN2 1248/4885KDM4E 2553/4885
US-11160734-B2 Personal care compositions comprising shaped abrasive particles POLR1C, PLOD3, C9 ALDH1A1 2882/4885SMN1; SMN2 1248/4885KDM4E 2553/4885
US-20130336903-A1 Personal Care Compositions Comprising a pH Tuneable Gellant and Methods of Using ARGLU1, F12, GALR1 ALDH1A1 2142/4885SMN1; SMN2 2669/4885KDM4E 772/4885
US-20130336902-A1 Personal Care Compositions Comprising a Di-Amido Gellant and Methods of Using PARN, PARG, CUTA ALDH1A1 2917/4885SMN1; SMN2 3589/4885KDM4E 2195/4885
US-20130039961-A1 Personal Care Compositions Comprising Shaped Abrasive Particles POLR1C, PLOD3, C9 ALDH1A1 2882/4885SMN1; SMN2 1248/4885KDM4E 2553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.